MedTrace Logo

Bariatric Endoscopy and NAFLD

NCT04669470 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2020-12-16

No results posted yet for this study

Summary

Find out how bariatric endocopy will influence clinical course of non alcoholic fatty liver disease.

Conditions

  • Obesity
  • NAFLD
  • Liver Steatosis
  • Liver Fibrosis

Interventions

PROCEDURE

bariatric endoscopy, mainly intragastric baloons, plication of stomach too

bariatric endoscopy, mainly intragastric baloons, plication of stomach too

Sponsors & Collaborators

  • University Hospital Olomouc

    collaborator OTHER

  • University Hospital Ostrava

    collaborator OTHER

  • Palacky University

    collaborator OTHER

  • University of Ostrava

    lead OTHER

Principal Investigators

  • Adam Vasura, MD · - Department of gastroenterology, hepatology and pancreatology, Internal clinic, University hospital Ostrava

  • Evzen Machytka · Department of gastroenterology, hepatology and pancreatology, Internal clinic, University hospital Ostrava

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-10-01
Primary Completion
2022-12-31
Completion
2023-12-31

Countries

  • Czechia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04669470 on ClinicalTrials.gov